Consistent with gene expression data, CD8 TIL density (including in tumor nests and stroma) and proliferating (CD8+Ki67+) and cytotoxic (CD3+Perforin+) T cells increased with tobemstomig treatment (P < 0.05) (Fig. 3d and Supplementary Fig. 4). This evidence concerns the gene PRF1 and neoplasm.